STAT3 and cervical cancer: We have demonstrated through in vitro and in vivo experiments that Bazedoxifene blocks the activation of STAT3 in cervical cancer, which can inhibit cervical cancer growth and affect EMT signaling and apoptosis associated with cancer cell migration and invasion.